FDA Approves DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Macleods Pharmaceuticals Limited

# FDA Approves Generic DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE Combination Macleods Pharmaceuticals Limited received FDA approval for its generic dapagliflozin and metformin hydrochloride combination (ANDA211559), marking another entry into the competitive diabetes treatment market and potentially increasing price competition for this widely-prescribed oral antidiabetic therapy. The approval is expected to expand treatment access and lower costs for patients managing type 2 diabetes while intensifying pricing pressure on branded competitors.